United States Pharmaceutical Secondary Packaging Market Size & Outlook, 2026-2034
United States Pharmaceutical Secondary Packaging Market Insights
- As highlighted in Packaging Market Insights analysis, the United States Pharmaceutical Secondary Packaging Market, worth USD 10090.86 Million in 2025, is forecasted to achieve USD 18445.04 Million by 2034.
- The United States market is anticipated to grow at a CAGR of 6.93% during the period 2026–2034.
- By 2025, Cartons represented the largest share of the Type market size.
- Corrugated Boxes is expected to remain the key growth driver within Type, registering the fastest CAGR during the forecast period.
Source: PIAnalysis Company Publications, Primary Interviews.
Other Key Findings
- In 2025, United States accounted for 22.23% of the global Pharmaceutical Secondary Packaging Market size.
- By 2034, United States is expected to lead the global Pharmaceutical Secondary Packaging Market in terms of market size.
- Within North America, United States is projected to dominate the regional Pharmaceutical Secondary Packaging Market size by 2034.
- Canada is identified as the fastest-growing market in North America, anticipated to reach USD 6896.45 Million by 2034.
Report Summary
| Report Scope | Details |
|---|---|
| Base Year for Study | 2025 |
| Study Period | 2022-2034 |
| Historical Period | 2022-2024 |
| Forecast Period | 2026-2034 |
| Market Size In 2025 | USD 10090.86 Million |
| Market Size In 2034 | USD 18445.04 Million |
| Largest segment | Cartons |
| Units | Revenue in USD Million |
| CAGR | 6.93% (2026-2034) |
| Segmnetation Covered | |
| Type |
|
| Application |
|
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends |
United States Pharmaceutical Secondary Packaging Market Type 2026-2034 (USD Million)
| Type | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cartons | XX.x | XX.x | XX.x | 5375.4 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Corrugated Boxes | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Labels & Leaflets | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: PIAnalysis Company Publications, Primary Interviews.
United States Pharmaceutical Secondary Packaging Market Application 2026-2034 (USD Million)
| Application | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Prescription Medicines | XX.x | XX.x | XX.x | 5012.13 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Over-the-Counter Medicines | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Biopharmaceutical Products | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: PIAnalysis Company Publications, Primary Interviews.